36 related articles for article (PubMed ID: 11783909)
1. Investigation of Trpa1 and Trpc1 Immunreactivities in Colon Adenocarcinomas.
Bozdag A; Kuloglu T; Artas G; Aydin S
Cancer Manag Res; 2024; 16():377-384. PubMed ID: 38699653
[TBL] [Abstract][Full Text] [Related]
2. Human intestinal organoids from Cronkhite-Canada syndrome patients reveal link between serotonin and proliferation.
Poplaski V; Bomidi C; Kambal A; Nguyen-Phuc H; Di Rienzi SC; Danhof HA; Zeng XL; Feagins LA; Deng N; Vilar E; McAllister F; Coarfa C; Min S; Kim HJ; Shukla R; Britton R; Estes MK; Blutt SE
J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37909332
[TBL] [Abstract][Full Text] [Related]
3. Case report: potential treatment of metastatic amphicrine carcinoma of the rectum with FOLFOXIRI chemotherapy.
Tamura N; Honma Y; Sekine S; Tsukamoto S; Hirano H; Okita N; Shoji H; Iwasa S; Takashima A; Kato K; Boku N
Oxf Med Case Reports; 2020 Nov; 2020(11):omaa097. PubMed ID: 33269082
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of Mixed Adenoneuroendocrine Carcinoma (MANEC) after Neoadjuvant Chemotherapy for Pancreatic and Gastric Adenocarcinoma: Two Case Reports and a Review of the Literature.
Oneda E; Liserre B; Bianchi D; Rota L; Savelli G; Zorzi F; Zaniboni A
Case Rep Oncol; 2019; 12(2):434-442. PubMed ID: 31275134
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine neoplasms of gastrointestinal tract and secondary primary synchronous tumors: A systematic review of case reports. Casualty or causality?
Parra-Medina R; Moreno-Lucero P; Jimenez-Moreno J; Parra-Morales AM; Romero-Rojas A
PLoS One; 2019; 14(5):e0216647. PubMed ID: 31086397
[TBL] [Abstract][Full Text] [Related]
6. Plasma serotonin level is a predictor for recurrence and poor prognosis in colorectal cancer patients.
Xia Y; Wang D; Zhang N; Wang Z; Pang L
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28543924
[TBL] [Abstract][Full Text] [Related]
7. Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.
Elshafae SM; Hassan BB; Supsavhad W; Dirksen WP; Camiener RY; Ding H; Tweedle MF; Rosol TJ
Prostate; 2016 Jun; 76(9):796-809. PubMed ID: 26939805
[TBL] [Abstract][Full Text] [Related]
8. Antidepressants in association with reducing risk of oral cancer occurrence: a nationwide population-based cohort and nested case-control studies.
Chung CM; Kuo TM; Chiang SL; Wang ZH; Hung CC; Lane HY; Liu CS; Ko YC
Oncotarget; 2016 Mar; 7(10):11687-95. PubMed ID: 26840257
[TBL] [Abstract][Full Text] [Related]
9. Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.
Rick FG; Buchholz S; Schally AV; Szalontay L; Krishan A; Datz C; Stadlmayr A; Aigner E; Perez R; Seitz S; Block NL; Hohla F
Cell Cycle; 2012 Jul; 11(13):2518-25. PubMed ID: 22751419
[TBL] [Abstract][Full Text] [Related]
10. Depletion of serotonin and selective inhibition of 2B receptor suppressed tumor angiogenesis by inhibiting endothelial nitric oxide synthase and extracellular signal-regulated kinase 1/2 phosphorylation.
Asada M; Ebihara S; Yamanda S; Niu K; Okazaki T; Sora I; Arai H
Neoplasia; 2009 Apr; 11(4):408-17. PubMed ID: 19308295
[TBL] [Abstract][Full Text] [Related]
11. Composite adenocarcinoma and large cell neuroendocrine carcinoma of the rectum.
Makino A; Serra S; Chetty R
Virchows Arch; 2006 May; 448(5):644-7. PubMed ID: 16508780
[TBL] [Abstract][Full Text] [Related]
12. Electron immunocytochemical demonstration of serotonin, vasoactive intestinal polypeptide, bombesin, somatostatin and glucagon in mirror biopsies from primary colorectal adenocarcinoma.
Seretis EC; Agnantis NJ; Golematis VC; Voloudakis-Balatzis IE
J Exp Clin Cancer Res; 2004 Sep; 23(3):477-84. PubMed ID: 15595639
[TBL] [Abstract][Full Text] [Related]
13. Mucinous colorectal adenocarcinoma with signet-ring cells: immunohistochemical and ultrastructural study.
Seretis E; Konstantinidou A; Arnogiannakis N; Xinopoulos D; Voloudakis-Baltatzis IE
Ultrastruct Pathol; 2010 Dec; 34(6):337-43. PubMed ID: 21070165
[TBL] [Abstract][Full Text] [Related]
14. Histological, immunohistochemical, ultrastructural and biochemical study of human gastric composite tumor: expression of the serotonin-2B receptor by the neuroendocrine component.
Brouland JP; Manivet P; Brocheriou-Spelle I; Wassef M; Le Bodic MF; Lavergne A; Launay JM
Endocr Pathol; 2001; 12(1):77-86. PubMed ID: 11478272
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine differentiation in sporadic CRC and hereditary nonpolyosis colorectal cancer.
Sun MH
Dis Markers; 2004; 20(4-5):283-8. PubMed ID: 15528794
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.
Kleist B; Poetsch M
World J Gastroenterol; 2015 Nov; 21(41):11740-7. PubMed ID: 26556999
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of serotonin and bombesin in adenocarcinomas and neuroendocrine tumors of the colon.
Seretis E; Gavrill A; Agnantis N; Golematis V; Voloudakis-Baltatzis IE
Ultrastruct Pathol; 2001; 25(6):445-54. PubMed ID: 11783909
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
